Comparison
3 Methylglutaconic Aciduria C3696376 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 3 Methylglutaconic Aciduria and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria C3696376
A metabolic disorder causing abnormal acid buildup affecting multiple body systems including the brain. Severity varies widely among affected individuals. Care focuses on symptom management and metabolic support.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
3 Methylglutaconic Aciduria C3696376
0-10
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
3 Methylglutaconic Aciduria C3696376
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria C3696376
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria C3696376
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
3 Methylglutaconic Aciduria C3696376
metabolic
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
3 Methylglutaconic Aciduria C3696376
metabolic
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-C3696376 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria C3696376 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Metabolic decompensation | May involve abnormal organic-acid buildup with neurologic or multisystem effects; severity varies. | Not primarily a metabolic aciduria; features reflect congenital developmental differences. | High |
| Developmental delay | May occur, often alongside metabolic or neurologic concerns. | Commonly associated with developmental delay and intellectual disability. | Moderate |
| Congenital features | Not defined by a chromosomal deletion; congenital findings are not the core description. | Associated with missing 3q13 material and variable congenital features. | High |
When to favor each condition
Choose 3 Methylglutaconic Aciduria C3696376 when
Unexplained neurologic or multisystem illness with suspected organic aciduria
The supplied description centers on abnormal acid buildup and metabolic support.
Moderate
Early-life metabolic concern
Reported onset is childhood, although exact timing varies.
Moderate
Need for metabolic rather than chromosomal evaluation
Category and body system are metabolic, not congenital chromosomal.
High
Choose 3q13 Microdeletion Syndrome C2931338 when
Developmental delay with suspected chromosomal cause
The condition is defined by missing chromosome 3q13 material.
High
Congenital features without a primary metabolic presentation
Source data emphasize congenital and developmental findings.
Moderate
Genetic counseling after a chromosomal finding
A microdeletion is a genetic diagnosis requiring specialist interpretation.
High
How key tests differ
| Test | 3 Methylglutaconic Aciduria C3696376 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Urine organic acids | May show abnormal organic-acid findings; exact cutoffs are not established here. | Not the defining test for a chromosomal microdeletion. | An abnormal result needs laboratory and clinician confirmation. |
| Chromosomal microarray | Not expected to define this metabolic disorder. | May identify missing 3q13 material when clinically indicated. | Genetic results require specialist interpretation. |
| Developmental assessment | May document neurologic or developmental effects when present. | Often relevant for developmental delay or intellectual disability. | Assessment supports care but does not distinguish etiology alone. |
Prognosis comparison
3 Methylglutaconic Aciduria C3696376
- Outcome
- Chronic course with widely variable severity; exact outcomes are not established here.
- Factors
- Extent of metabolic and neurologic involvement and response to supportive care.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Chronic congenital condition, generally described as moderate but individually variable.
- Factors
- Developmental profile, intellectual disability, and congenital features.
Time frame: Long-term; precise timelines are not supplied.
Diagnosis confirmation, associated findings, and access to specialist support influence outlook.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic effects | Brain involvement is described, with widely variable severity. Developmental delay and intellectual disability are associated features. Neither source establishes a uniform neurologic course. |
| Multisystem involvement | Multiple body systems may be affected by metabolic disturbance. Variable congenital features may involve several systems. Specific complications should be assessed individually. |
| Long-term support needs | Care emphasizes symptom management and metabolic support. Support commonly addresses development, learning, and congenital needs. Support intensity is not predictable from these descriptions alone. |
Patient education highlights
- HighDifferent causes
One is a metabolic disorder; the other is a chromosomal microdeletion. Testing and care pathways differ.
- HighVariable course
Severity and features vary. A clinician should interpret results in the full clinical context.
- MediumFollow-up
Report new neurologic, developmental, feeding, or illness concerns promptly to the care team.